Monica Arnedos Selected Research

Phosphotransferases (Kinase)

1/2020	Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer.
3/2012	Functional characterization of the 19q12 amplicon in grade III breast cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Monica Arnedos Research Topics

Disease

26	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2007
20	Neoplasms (Cancer) 01/2022 - 12/2007
2	Triple Negative Breast Neoplasms 01/2021 - 07/2012
2	Lobular Carcinoma 07/2014 - 02/2011
1	Mucositis 10/2021
1	Exanthema (Rash) 10/2021
1	COVID-19 01/2021
1	Disease Progression 01/2020
1	Aneuploidy (Aneuploid) 11/2019
1	Rare Diseases (Rare Disease) 01/2014
1	Neoplasm Metastasis (Metastasis) 02/2011
1	Carcinoma (Carcinomatosis) 02/2011
1	Pain (Aches) 11/2008
1	Sepsis (Septicemia) 11/2008
1	Neutropenia 11/2008
1	Infertility (Sterility) 08/2008

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 10/2021 - 02/2011
5	Hormones (Hormone)IBA 01/2022 - 11/2007
4	Trastuzumab (Herceptin)FDA Link 10/2021 - 02/2014
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 03/2012
4	Estrogen ReceptorsIBA 01/2020 - 07/2012
3	Pharmaceutical PreparationsIBA 01/2020 - 02/2013
3	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 06/2012
3	Letrozole (Femara)FDA LinkGeneric 11/2014 - 11/2007
2	GenieIBA 01/2022 - 01/2020
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2021 - 07/2012
2	Everolimus FDA Link 10/2021 - 10/2017
2	Biological ProductsIBA 10/2021 - 03/2013
2	TOR Serine-Threonine KinasesIBA 10/2021 - 10/2017
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 11/2013
2	Fulvestrant (Faslodex)FDA Link 01/2020 - 10/2019
2	Phosphotransferases (Kinase)IBA 01/2020 - 03/2012
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2019 - 11/2008
2	Phenobarbital (Luminal)FDA Link 10/2019 - 05/2015
2	Epidermal Growth Factor (EGF)IBA 05/2016 - 02/2014
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 03/2013 - 07/2012
2	Aromatase InhibitorsIBA 06/2012 - 11/2007
1	rucaparibIBA 12/2021
1	AntibodiesIBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	durvalumabIBA 01/2021
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 01/2021
1	KetonesIBA 01/2021
1	neratinibIBA 01/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 11/2019
1	Taxoids (Taxanes)IBA 11/2019
1	CyclinsIBA 10/2019
1	palbociclibIBA 10/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2017
1	MTOR InhibitorsIBA 02/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	LigandsIBA 03/2013
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2012
1	human ERBB2 proteinIBA 07/2012
1	Progesterone Receptors (Progesterone Receptor)IBA 07/2012
1	Aromatase (CYP19)IBA 06/2012
1	ParaffinIBA 06/2012
1	Formaldehyde (Formol)FDA Link 06/2012
1	Cyclin-Dependent Kinase 2IBA 03/2012
1	Monoclonal AntibodiesIBA 02/2011
1	Cadherins (E-Cadherin)IBA 02/2011
1	CateninsIBA 02/2011
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2008
1	Goserelin (Zoladex)FDA Link 08/2008
1	Tamoxifen FDA LinkGeneric 12/2007
1	exemestane (Aromasin)FDA Link 11/2007
1	Anastrozole (Arimidex)FDA LinkGeneric 11/2007

Therapy/Procedure

11	Therapeutics 01/2021 - 04/2007
5	Neoadjuvant Therapy 11/2019 - 11/2008
4	Adjuvant Chemotherapy 05/2015 - 08/2008
3	Drug Therapy (Chemotherapy) 01/2021 - 07/2012
2	Precision Medicine 12/2015 - 01/2014
1	Maintenance Chemotherapy 01/2021
1	Ketogenic Diet 01/2021
1	Time-to-Treatment 11/2019
1	Mastectomy (Mammectomy) 07/2014
1	Conservative Treatment 07/2014
1	Aftercare (After-Treatment) 08/2013
1	Treatment Delay 11/2008
1	Drug Tapering 11/2008